Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about CRRT therapy along with the increase in the launch of advanced CRRT system area anticipated to fuel the CRRT market growth during the forecast period.
According to a new market research report, "Continuous Renal Replacement Therapy (CRRT) Market by Product (Disposables (Hemofilters, Bloodlines), Machine, Dialysates, Renal Replacement fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF), Patient (Adult, Pediatrics, Neonates) - Global Forecasts to 2026", The global Continuous Renal Replacement Therapy (CRRT) market size is projected to reach USD 1.7 billion by 2026 from USD 1.2 billion in 2021, at a CAGR of 7.3% during the forecast period.
Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to boost the growth of the market. Moreover, presence of well-established key players focusing on developing and commercializing technologically advanced and initiatives undertaken by government to increase the awareness about CRRT are likely to propel the market growth during the forecast period.
The growing demand for dialysate to support the market growth during the forecast period.”
The significant rise in demand for CRRT in the treatment of hemodynamically unstable patients. Moreover, the development and commercialization of novel renal replacement solutions also support market growth. Furthermore, many companies are expanding their dialysate product portfolios. For instance, in August 2020, NIPRO CORPORATION acquired shares in dialysate MTN Neubrandenburg GmbH, involved in the manufacturing and sales of dialysates.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246917088
The growing worldwide incidence of AKI/AKF is, therefore, expected to increase the demand for CRRT. According to the International Society of Nephrology (INR), an estimated 13.3 million cases of AKI are registered annually worldwide.
This is anticipated to boost the adoption of continuous renal replacement therapy at a rapid rate. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to propel the growth of the CRRT market at a significant rate during the forecast period.
CRRT is a highly specialized and critical therapy that involves complex nursing care. Properly trained ICU nurses are required for the continuous assessment of indications, ensuring good vascular access, avoiding unnecessary interruptions, and preventing complications in patients during CRRT. However, currently, there is a dearth of registered nurses in ICU settings. Moreover the complexity associated with CRRT are likely to hinder the market growth.
By product, dialysates replacement fluid segment is to capture largest market share during the forecast period
The largest market share of this segment is attributed to factors such growing demand for dialysates to remove undesired solutes and restoring the electrolytes and acid-base balance in the blood along with presence of well established players with strong offerings in dialysates replacement fluid
continuous venovenous hemodiafiltration (CVVHDF) is to have highest growth rate of the CRRT market, by modality during the forecast period.
The high growth rate of the CVVHDF segment can be attributed to its flexibility as compared to other CRRT modalities. The CVVHDF modality also combines the benefits of convection and diffusion for the removal of solutes, which is another major factor supporting its growth.